Psychemedics Corporation PMD
2.67
0.00
0.00%
as of 2 Mar
- Market cap
- $15.7M
- P/E
- 0.0×
Follow PMD
| Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.68 | 19.12 | 18.68 | 19.58 |
P/S ratio |
0.67 | 0.88 | 1.10 | 1.56 | 1.32 | 1.34 | 2.05 | 2.86 | 3.35 |
P/FCF ratio |
16.33 | 0.00 | 6.05 | 393.47 | 0.00 | 22.02 | 14.15 | 15.39 | 18.60 |
P/Operating CF |
12.90 | 29.39 | 14.64 | 68.95 | 24.66 | 53.22 | 22.26 | 55.99 | 40.89 |
P/B ratio |
2.56 | 2.92 | 2.58 | 3.18 | 2.25 | 3.00 | 4.66 | 6.10 | 8.38 |
Price to Tangible BV |
2.56 | 2.92 | 2.58 | 3.18 | 2.25 | 3.00 | 4.66 | 6.10 | 8.38 |
EV/Sales |
0.61 | 0.81 | 0.93 | 1.53 | 1.38 | 1.22 | 1.90 | 2.74 | 3.34 |
EV/EBITDA |
63.87 | 0.00 | 10.56 | 9.80 | 0.00 | 7.75 | 7.59 | 9.92 | 10.49 |
EV/Operating CF |
12.93 | (12.08) | 4.82 | 92.33 | (7.20) | 10.63 | 10.21 | 11.90 | 14.04 |
EV/FCF |
14.92 | (10.45) | 5.14 | 386.11 | (5.71) | 19.99 | 13.12 | 14.74 | 18.52 |
Quick Ratio |
1.45 | 1.20 | 1.54 | 1.51 | 2.20 | 1.98 | 3.15 | 2.99 | 2.17 |
Current Ratio |
1.82 | 1.45 | 1.74 | 1.76 | 2.44 | 2.20 | 3.42 | 3.28 | 2.41 |
Net Debt/EBITDA |
(7.26) | 6.61 | (1.86) | (0.19) | (0.53) | (0.79) | (0.59) | (0.44) | (0.04) |
Debt/Assets |
0.64% | 2.47% | 3.20% | 5.86% | 17.21% | 9.55% | 6.52% | 12.74% | 13.51% |
Debt/Equity |
0.01 | 0.05 | 0.06 | 0.10 | 0.33 | 0.16 | 0.09 | 0.18 | 0.22 |
Asset Turnover |
1.91 | 1.42 | 1.25 | 1.09 | 0.83 | 1.44 | 1.66 | 1.54 | 1.66 |
Operating CF/Net income |
(0.50) | 0.36 | (4.51) | (0.62) | 1.06 | 2.79 | 1.73 | 1.49 | 1.39 |
Capex/Depreciation |
(0.04) | (0.06) | (0.06) | (0.05) | (0.23) | (0.58) | (0.39) | (0.43) | (0.88) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (31.54%) | (47.63%) | (9.42%) | (5.37%) | (26.31%) | 8.67% | 24.54% | 35.77% | 48.96% | |
| (18.03%) | (26.75%) | (5.38%) | (2.92%) | (14.98%) | 5.87% | 17.81% | 23.75% | 28.38% | |
ROIC |
(31.42%) | (36.42%) | (10.22%) | 1.13% | (27.45%) | 15.40% | 38.35% | 36.86% | 41.99% |
Return on Tangible Assets |
(44.02%) | (80.55%) | (12.29%) | (5.97%) | (25.92%) | 8.63% | 22.93% | 28.53% | 33.87% |
Average Days of Receivables |
46.80 | 61.20 | 58.97 | 99.55 | 99.98 | 41.29 | 41.30 | 41.26 | 54.66 |
Research and Development Expense of Revenue |
3.80% | 5.18% | 5.25% | 4.54% | 5.99% | 4.16% | 3.63% | 3.42% | 3.63% |
Selling, General and Administrative Expense of Revenue |
41.88% | 46.11% | 35.85% | 35.83% | 45.28% | 31.53% | 26.85% | 25.96% | 25.46% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.66% | 4.11% | 3.45% | 2.98% | 2.64% | 2.01% | 1.39% | 1.47% | 1.72% |
Graham Net Nets |
0.13 | 0.06 | 0.07 | 0.03 | (0.07) | 0.04 | 0.09 | 0.05 | 0.01 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.38 | 7.98 | 9.21 | 8.89 |
Earnings Yield |
(14.29%) | (21.24%) | (3.91%) | (1.78%) | (13.75%) | 3.06% | 5.23% | 5.35% | 5.11% |
Free Cash Flow Yield |
6.13% | (8.79%) | 16.53% | 0.25% | (18.32%) | 4.54% | 7.07% | 6.50% | 5.38% |
Revenue per Share |
3.36 | 3.85 | 4.49 | 4.49 | 3.87 | 6.83 | 7.76 | 7.24 | 7.16 |
Operating CF per Share |
0.16 | (0.26) | 0.87 | 0.07 | (0.74) | 0.78 | 1.44 | 1.67 | 1.70 |
Capex per Share |
(0.01) | (0.03) | (0.03) | (0.03) | (0.15) | (0.30) | (0.22) | (0.22) | (0.37) |
Free Cash Flow per Share |
0.14 | (0.29) | 0.84 | 0.04 | (0.89) | 0.48 | 1.22 | 1.45 | 1.33 |
Cash per Share |
0.24 | 0.34 | 0.84 | 0.36 | 0.51 | 1.32 | 1.45 | 1.49 | 0.72 |
Shareholders Equity per Share |
0.87 | 1.16 | 1.91 | 2.21 | 2.27 | 3.05 | 3.41 | 3.40 | 2.87 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.87 | 1.16 | 1.91 | 2.21 | 2.27 | 3.05 | 3.41 | 3.40 | 2.87 |
Free Cash Flow |
0.84 | (1.64) | 4.70 | 0.23 | (4.93) | 2.63 | 6.74 | 7.95 | 7.26 |
Working Capital |
2.23 | 2.10 | 4.25 | 4.46 | 5.66 | 7.02 | 9.81 | 9.64 | 6.36 |
Capital Expenditures |
(0.09) | (0.16) | (0.19) | (0.18) | (0.85) | (1.68) | (1.19) | (1.20) | (2.01) |
Net Current Asset Value |
1.75 | 1.15 | 2.00 | 0.98 | (1.89) | 2.14 | 7.64 | 5.98 | 1.43 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 182.89 | 0.00 | 15.28 | 10.64 | 13.34 | 12.88 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.03 | 0.03 | 0.05 |
Net Profit Margin |
(9.45%) | (18.80%) | (4.29%) | (2.67%) | (18.07%) | 4.09% | 10.74% | 15.42% | 17.13% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 186.38 | 0.00 | 16.83 | 11.47 | 13.93 | 12.93 |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.04 | 0.87 | 0.73 | 0.55 | 0.39 | 0.27 | 0.30 | 0.24 | 0.17 |
Cash ROIC |
(16.24%) | (50.79%) | 1.97% | (40.50%) | (68.36%) | (24.51%) | (7.93%) | (8.84%) | (17.84%) |
Accounts Receivable Turnover |
6.32 | 5.68 | 4.64 | 3.94 | 4.22 | 8.29 | 9.16 | 7.69 | 7.63 |
Accounts Payable Turnover |
20.73 | 22.81 | 22.12 | 18.64 | 27.59 | 32.69 | 40.84 | 22.58 | 16.62 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
13.40 | 20.06 | 10.25 | 24.77 | 12.78 | 10.61 | 11.29 | 7.31 | 28.38 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3.11 | 3.89 | 5.44 | 6.32 | 5.06 | 4.55 | 4.66 | 5.16 | 5.11 |
Average Payables |
0.61 | 0.60 | 0.72 | 0.79 | 0.60 | 0.65 | 0.54 | 0.88 | 1.06 |
Average Assets |
10.32 | 15.53 | 20.14 | 22.78 | 25.77 | 26.25 | 25.74 | 25.77 | 23.53 |
Average Common Equity |
5.90 | 8.72 | 11.51 | 12.38 | 14.67 | 17.78 | 18.68 | 17.11 | 13.64 |
Columns are period end dates